Apparatus and method for delivering therapeutic and diagnostic agents

• US 6,565,528 B1
• Filed: 05/05/2000
• Issued: 05/20/2003
• Est. Priority Date: 05/07/1999
• Status: Expired due to Fees

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Scimed Life Systems Incorporated (Boston Scientific Corporation)
• Inventors: Mueller, Richard
• Primary Examiner(s): Walberg, Teresa
• Assistant Examiner(s): FASTOVSKY, LEONID M
• Application Number:
  US09/566,196
• Time in Patent Office: 1,110 Days
• Field of Search: 604/106, 604/104, 604/108, 604/187, 604/500, 604/95, 604/22, 600/407, 600/437, 606/200, 606/108
• US Class Current: 604/106
• CPC Class Codes: A61B 17/221 Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions surgical snare instruments A61B17/32056
• CPC Class Codes: A61B 17/3207 Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions A61B17/32037 takes precedence; endoscopic cutting instruments A61B17/320016
• CPC Class Codes: A61B 2017/00247 Making holes in the wall of the heart, e.g. laser Myocardial revascularization
• CPC Class Codes: A61B 2017/22077 with a part piercing the tissue A61B2017/22044 takes precedence
• CPC Class Codes: A61B 2017/22082 after introduction of a substance
• CPC Class Codes: A61B 2017/2212 having a closed distal end, e.g. a loop
• CPC Class Codes: A61B 2018/00392 Transmyocardial revascularisation
• CPC Class Codes: A61B 2090/064 for measuring force, pressure or mechanical tension
• CPC Class Codes: A61M 2025/0089 Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip
• CPC Class Codes: A61M 2210/125 Heart

Abstract

A drug-delivery tool and method for delivering a diagnostic or therapeutic agent to a target site within a selected body tissue, such as the myocardium of the heart, is disclosed. The drug-delivery tool generally includes an accessing device having a tissue-penetrating implement in its distal-end region, and elements for delivering a selected agent into a cavity formed by the implement.

Claims

1. A drug-delivery tool for delivering a drug to body tissue, such as a heart-wall, comprising:

(a) an accessing device having distal and proximal ends, an inner lumen extending therebetween, a drug-delivery reservoir adapted to hold such drug, and a user-control structure at the accessing device'"'"'s proximal end,

(b) a tissue-penetrating implement carried at the accessing device'"'"'s distal end for axial movement into and out of the lumen, the implement having first and second expandable members which are disposed in a substantially co-extension condition, when the implement is disposed in a retracted condition within the lumen, and an expanded, spaced-apart condition when the implement is advanced to an extended condition out of the lumen, at least one of the members having a tip for penetrating such tissue

(c) a first operative connection between the control structure and the implement which is operable, upon user activation of the control structure, to advance the implement from its retracted to its extended condition, wherein, when the accessing device'"'"'s distal end is placed against a surface region of the tissue, the implement is advanced into the tissue, causing the two expandable members to expand to form a cavity within the tissue, and

(d) a second operative connection between the control structure and the reservoir which is operable, upon user activation of the control structure, to deliver drug from the reservoir into such cavity.

2. The tool of claim 1, wherein the implement includes at least two expandable elements which move away from one another as the implement is being advanced, from its retracted to its extended condition, into such tissue, to form a cavity in the tissue.

3. The tool of claim 1, wherein the second expandable member of the tissue-penetrating implement defines a lumen having a plurality of openings in fluid communication with the drug-delivery reservoir such that the drug may be introduced into the cavity formed by the tool and at least about 90% of the surface area of the tissue directly borders the cavity.

4. The tool of claim 1, wherein the accessing device is a flexible catheter accessing device;

and further comprising

(i) a pull-wire assembly extending longitudinally through the catheter accessing device, the pull-wire assembly being operable to deflect the distal end of the accessing device substantially within a plane; and

(ii) one or more force contact transducers mounted at the distal end of the accessing device within the deflection plane.

5. The tool of claim 4, further comprising one or more additional force contact transducers mounted at the distal end of the accessing device outside of the deflection plane.

6. The tool of claim 1, wherein the accessing device is incorporated in an endoscope assembly.

7. The tool of claim 1, wherein the tissue-penetrating implement includes

(i) a cutting or slicing tip on the first expandable member;

and

(ii) one or more resiliently flexible second expandable members being adapted to expand radially outward in their normal state.

8. The tool of claim 1, wherein a drug-delivery passage is formed by an elongate conduit having an internal lumen that extends between the tissue-penetrating implement and drug-delivery reservoir;

the conduit being adapted for sliding movement within the accessing device, coupled with movement of the tissue-penetrating implement.

9. The tool of claim 8, for use in delivering a selected drug having a net negative charge, further comprising first and second electrodes adapted to be placed in electrical communication with a power supply, with the first electrode being disposed at a distal region of the tissue-penetrating implement and the decond electrode being disposed proximally of the tissue-penetrating implement;

wherein generation of a positive charge at the first terminal is effective to draw at least a member of the negatively charge species from the drug-delivery passage into the expandable members of the tissue-penetrating implement.

10. The tool of claim 1, for use with solid or semi-solid agents, wherein the second expandable member of the tissue-penetrating implement comprises a plurality of resiliently flexible expandable members disposed at spaced positions about the longitudinal axis of the tool so as to define a cage or skeleton capable of holding such an agent as it is placed in a cavity formed by the implement.

11. The tool of claim 1, wherein at least one of the expandable members has a tissue-penetrating tip, and at least one of the expandable members has a cutting tip for slicing tissue in the direction of expansion of the implement members, wherein when the implement is being advanced into such tissue, from its retracted to its extended condition, the implement forms a drug-receiving pocket in the tissue.

12. The tool of claim 1, 2, 3, 4, or 5, wherein the first expandable member further comprises construction from a shape memory material capable of a first remembered curved shape, and a second, stress induced linear shape causing the first expandable member to cut in an arc shape as it is advanced through a tissue.

13. The tool of claims 1, 2, 4, or 5, wherein the second expandable member comprises a ribbed balloon, wherein each rib defines a lumen in communication with the drug-delivery reservoir, and each rib further defines a plurality of exit ports from the rib lumen that the drug may perfuse through.

14. The tool of claims 1, 2, 4, or 5, wherein the first expandable member is a cork-screw shaped tubular member defining a lumen in communication with the drug-delivery reservoir, wherein the first expandable member is rotatable along its axis to permit it to screw into a tissue upon axial rotation.

36. The tool of claim 1, wherein the accessing device is incorporated in an open surgical assembly.

15. A method for delivering a selected diagnostic or therapeutic agent to a target site within a selected body tissue, comprising:

(i) forming a cut or slice extending from a wall of the selected tissue to the target site;

(ii) moving the tissue bordering the cut or slice radially outward, thereby forming a cavity within the tissue at the target site;

(iii) delivering a selected agent into the cavity; and

(iv) permitting the cavity to collapse once a selected amount of the agent has been delivered therein.

16. The method of claim 15, wherein step (i) is effected using a cutting or slicing implement that is configured to avoid the removal of tissue along the region of the cut or slice beyond the inherent cellular injury due to the cutting or slicing.

17. The method of claim 15, wherein the implement is a blade edge or tip.

18. The method of claim 15, wherein the cut or slice formed in step (i) is made along a substantially linear axis, with the axis being oriented generally normal to the wall of the selected tissue.

19. The method of claim 16, wherein the agent is delivered using an elongate agent-delivery conduit defining a passage or lumen terminating at a distal orifice through which the agent can exit;

and wherein, during delivery of the agent, the orifice does not make substantial contact with the selected tissue, thereby maximizing the tissue surface area available for contact with the agent.

20. The method of claim 15, wherein the selected tissue is heart tissue, and the cut or slice is formed from an endocardial wall, a septal wall, or an epicardial wall.

21. The method of claim 18, wherein the selected tissue is myocardial tissue, and the selected agent includes a species having angiogenic properties.

22. The method of claim 15, wherein the selected tissue is myocardial tissue, and the selected agent includes a nucleic acid.

23. The method of claim 15, wherein the selected tissue is stunned, ischemic or hibernating organ tissue that has at least partially lost its normal capillary ability at natural vasomotion.

24. An drug-delivery tool for delivering a selected diagnostic or therapeutic agent to a target site within a selected body tissue, comprising:

an accessing device having proximal and distal ends, with a lumen extending between said ends and terminating at an orifice at said distal end;

a tissue-penetrating implement movable between a retracted condition, within a distal region of said lumen, and an extended condition, extending out of said orifice;

wherein said implement includes (i) a tip configured to penetrate a selected body tissue when the distal end of the accessing device is placed there against and the implement is moved from its retracted condition to its extended condition, and (ii) an expandable member disposed proximal of said tip for following the tip to a target site within such tissue, and adapted to expand radially, with the implement at its extended condition, with sufficient force to form a cavity at the target site by pressing the tissue at the target site away from the longitudinal axis of the implement; and

an agent-delivery passage disposed longitudinally between the proximal and distal ends of said accessing device, with a distal end of said passage defining an exit port for directing a selected agent, which is passed through the passage, into a central region of the expandable member and any such cavity formed thereby.

25. The drug-delivery tool of claim 24, wherein said expandable member of said tissue-penetrating implement defines a plurality of openings that permit direct communication of an agent passed into a cavity formed by said implement with at least about 90% of the surface area of the tissue directly bordering the cavity.

26. The drug-delivery tool of claim 24, wherein the accessing device is a flexible catheter accessing device;

and further comprising (i) a pull-wire assembly extending longitudinally through said catheter accessing device, said pull-wire assembly being operable to deflect a distal-end region of said accessing device substantially within a plane; and

(ii) one or more ultrasound transducers mounted at the distal end of the accessing device within said deflection plane.

27. The drug-delivery tool of claim 26, further comprising one or more additional ultrasound transducers mounted at the distal end of the accessing device outside of said deflection plane.

28. The drug-delivery tool of claim 24, wherein the accessing device is incorporated in an endoscope assembly.

29. The drug-delivery tool of claim 24, wherein the tissue-penetrating implement includes (i) a cutting or slicing tip at its distal-end region, and (ii) one or more resiliently flexible expandable members extending proximally therefrom, with said expandable members being adapted to expand radially outward in their normal state.

30. The drug-delivery tool of claim 29, further comprising an actuation line attached to a proximal end of said implement and extending to the proximal end of said accessing device, with said line being adapted for sliding movement within said accessing device;

whereupon movement of said accessing device effects movement of said implement.

31. The drug-delivery tool of claim 24, wherein said agent-delivery passage is formed by an elongate conduit having an internal lumen that extends between the proximal end of the accessing device and a distal-end region of the accessing device;

said conduit being adapted for sliding movement within said accessing device, coupled with movement of said tissue-penetrating implement.

32. The drug-delivery tool of claim 24, for use in delivering a selected agent having a net negative charge, further comprising first and second electrodes adapted to be placed in electrical communication with a power supply, with the first electrode being disposed at a distal region of said tissue-penetrating implement and the second electrode being disposed proximally of the implement;

wherein generation of a positive charge at said first terminal is effective to draw at least a member of the negatively charge species from the agent-delivery passage into the expandable member of the tissue-penetrating implement.

33. The drug-delivery tool of claim 24, for use with solid or semi-solid agents, wherein said expandable member of said tissue-penetrating implement comprises a plurality of resiliently flexible expandable members disposed at spaced positions about the longitudinal axis of the implement so as to define a cage or skeleton capable of holding such an agent as it is placed in a cavity formed by the implement.

37. The drug-delivery tool of claim 24, wherein the agent-delivery passage is substantially co-extensive with the lumen.

34. A drug-delivery tool for delivering a selected diagnostic or therapeutic agent to a target site within a selected body tissue, comprising:

(i) an accessing device having proximal and distal ends, with a lumen extending between said ends and terminating at an orifice at said distal end;

(ii) a tissue-penetrating implement movable between a retracted condition, within a distal region of said lumen, and an extended condition, extending out of said orifice;

wherein said implement includes (i) a tip configured to penetrate a selected body tissue when the distal end of the accessing device is placed there against and the implement is moved from its retracted condition to its extended condition, and (ii) a cage member disposed proximal of said tip for following the tip to a target site within such tissue, and adapted to assist in the formation and maintenance of a cavity at the target site by pressing the tissue at the target site away from the longitudinal axis of the implement as it is inserted therein and having sufficient rigidity to resist inwardly directed forces of the tissue tending to collapse the cavity; and

(iii) an agent-delivery passage disposed longitudinally between the proximal and distal ends of said accessing device, with a distal end of said passage defining an exit port facing said cage member for directing a selected agent, which is passed through the passage, into a central region of the cage member and any such cavity formed thereby.

35. The drug-delivery tool of claim 34, wherein at least 90% of the surface area of the tissue bordering the cavity is directly exposed to the cavity, so that an agent delivered into the cavity can pass directly into the exposed tissue.

38. The drug-delivery tool of claim 34, wherein the agent-delivery passage is substantially co-extensive with the lumen.